On April 30, the Federal Trade Commission (FTC) announced that it was expanding its campaign against allegedly improper patent listings in the U.S. Food & Drug Administration’s (FDA) Orange Book.
Glaxo Smith Kline (GSK) announced in May that Flovent HFA, a metered-dose inhaler, as well as Flovent Diskus, a dry powder inhaler, would be discontinued as of Dec. 31, 2023. Experts shared comment.
If you or your child use a Flovent inhaler, now is a good time to get it refilled (if you can), and then call the doctor about updating your prescription. The company that makes Flovent is discontinuing the name brand version, and the generic (fluticasone) may not be covered under all plans.